Login to Your Account

Phytopharm Gets Obesity Drug Back From Pfizer, Seeks Partner

By Nuala Moran

Wednesday, August 6, 2003
LONDON - Phytopharm plc fell victim to the fallout from Pfizer Inc.'s $66 billion acquisition of Pharmacia Corp., as Pfizer dropped development of P57, an obesity treatment based on a plant extract discovered by Phytopharm. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription